Deal notes
The $19,135,717 figure is available ATM offering capacity under the disclosed public-float limit, not cash raised. Shares may be sold over time; actual sales, proceeds and a fixed offering price are not established by these filings.
Original source ↗Transaction overview
01VirnetX Holding Corp disclosed an at-the-market program event: facility established. Available capacity is $19.1M. This event does not record cash proceeds raised.
- Financing type
- ATM
- Announcement date
- —
- SEC disclosure date
- Oct 1, 2026
- Agreement date
- Oct 1, 2026
- Pricing date
- —
- Closing date
- —
- Filing date
- Oct 1, 2026
- Status
- Announced
- Market cap before SEC disclosure
- $38.4M
- Prior closing price
- $10.19
- Raise as % of market cap
- —
Market data · FMP
- Historical market cap
- $38,416,300
- Market date
- Sep 30, 2026
- Closing price
- $10.19
- Latest reported shares outstanding
- 4,185,850
- Latest reported float shares
- 3,524,362
- Share-data date
- Oct 8, 2026
Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Oct 8, 2026.
Financial Modeling Prep ↗Financing terms
02At-the-market program
- Capital event
- Facility established
- Available capacity
- $19.1M
- Proceeds raised
- Not reported as raised
- Shares sold
- —
- Average sale price
- —
- Relevant period
- Not applicable
- Sales commission
- 3%
Security structure
- Price / security basis
- Common shares
- Units offered
- —
- Preferred class
- Not applicable
- Preferred shares offered
- —
Fees & transaction economics
03- Placement agent / underwriting fee
- 3%
- Agent fee amount
- —
- Management fee
- —
- Other offering expenses (estimated)
- —
- Net proceeds (estimated)
- —
- Net proceeds as % of gross
- —
Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.
Transaction participants
04Source documents
05SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.
Filing evidence & original calculations
Common shares
We have entered into a sales agreement, dated as of October 1, 2026 (the “Sales Agreement”) with Titan Partners Securities LLC (the “Agent”) relating to shares of our common stock, par value $0.0001 per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $19,135,717 from time to time through the Agent, acting as our sales agent.Original source ↗
ATM
We have entered into a sales agreement, dated as of October 1, 2026 (the “Sales Agreement”) with Titan Partners Securities LLC (the “Agent”) relating to shares of our common stock, par value $0.0001 per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $19,135,717 from time to time through the Agent, acting as our sales agent.Original source ↗
Announced
We have entered into a sales agreement, dated as of October 1, 2026 (the “Sales Agreement”) with Titan Partners Securities LLC (the “Agent”) relating to shares of our common stock, par value $0.0001 per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $19,135,717 from time to time through the Agent, acting as our sales agent.Original source ↗
3
We will pay the Agent a cash commission of 3% of the gross sales price of common stock that the Agent sells pursuant to the Sales Agreement. Because there is no minimum offering amount required as a condition to this offering, the actual total offering amount, commissions and proceeds to us, if any, are not determinable at this time.Original source ↗
sec_disclosure
We have entered into a sales agreement, dated as of October 1, 2026 (the “Sales Agreement”) with Titan Partners Securities LLC (the “Agent”) relating to shares of our common stock, par value $0.0001 per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $19,135,717 from time to time through the Agent, acting as our sales agent.Original source ↗
2026-10-01
We have entered into a sales agreement, dated as of October 1, 2026 (the “Sales Agreement”) with Titan Partners Securities LLC (the “Agent”) relating to shares of our common stock, par value $0.0001 per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $19,135,717 from time to time through the Agent, acting as our sales agent.Original source ↗
2026-10-01
On October 1, 2026, in connection with the launch of an “at the market” offering program, VirnetX Holding Corporation (the “Company”) entered into an At the Market Offering Agreement (the “Sales Agreement”) with Titan Partners Securities LLC, as sales agent, (the “Agent”) pursuant to which the Company may sell, from time to time, an aggregate of up to $19,135,717 of shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”).Original source ↗
Facility established
On October 1, 2026, in connection with the launch of an “at the market” offering program, VirnetX Holding Corporation (the “Company”) entered into an At the Market Offering Agreement (the “Sales Agreement”) with Titan Partners Securities LLC, as sales agent, (the “Agent”) pursuant to which the Company may sell, from time to time, an aggregate of up to $19,135,717 of shares (the “Shares”) of its common stock, par value $0.0001 per share (the “Common Stock”).Original source ↗
Available capacity
The aggregate market value of our outstanding shares of common stock held by non-affiliates was $57,407,153 based on 4,196,009 shares of common stock outstanding as of September 29, of which 3,585,706 shares are held by non-affiliates, and a per share price of $16.01 based on the closing sale price of our common stock on August 6, 2026. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75.0 million. During the 12-month period prior to and including the date of this prospectus supplement, we did not offer any securities pursuant to General Instruction I.B.6 of Form S-3.Original source ↗
19135717
We have entered into a sales agreement, dated as of October 1, 2026 (the “Sales Agreement”) with Titan Partners Securities LLC (the “Agent”) relating to shares of our common stock, par value $0.0001 per share (“common stock”), offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the Sales Agreement, we may offer and sell shares of our common stock having an aggregate offering price of up to $19,135,717 from time to time through the Agent, acting as our sales agent.Original source ↗
FMP reported market cap; as of 2026-09-30.
{"provider":"FMP","policy":"fmp-primary-v1","symbol":"VHC","marketCap":38416300,"closingPrice":10.19,"asOf":"2026-09-30","retrievedAt":"2026-10-08T17:43:30.603943+00:00","outstandingShares":4185850,"floatShares":3524362,"sharesAsOf":"2026-10-08","sharesBasis":"latest_provider_snapshot","marketCapSource":"https://site.financialmodelingprep.com/developer/docs","priceSource":"https://site.financialmodelingprep.com/developer/docs","sharesSource":"https://site.financialmodelingprep.com/developer/docs"}Original source ↗